A. Shotan et al., Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era - A national study, AM HEART J, 141(3), 2001, pp. 478-484
Citations number
30
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background Patients with recurrent acute myocardial infarction (AMI) are at
increased risk for morbidity and mortality. We compared the outcome of pat
ients with recurrent AMI hospitalized in coronary care units in the prerepe
rfusion and reperfusion eras.
Methods The study population comprised 2 large-scale cohorts with recurrent
AMI: (1) 1415 (24%) of 5839 consecutive patients with AMI hospitalized in
1981 to 1983 (Secondary Prevention Reinfarction Israeli Nifedipine Trial [S
PRINT] Registry) and (2) 1093 (25%) of 4317 patients with AMI From three na
tional surveys performed in 1992 to 1996.
Results Patients in the 1990s hod significantly lower roles of heart failur
e and cardiogenic shock. The 7-day mortality declined From 18% in 1981-1983
to 10% in 1992-1996 (adjusted odds ratio [OR] 0.57 [0.44-0.75]), the 30-da
y mortality rate from 26% to 16% (OR 0.56 [0.44-0.71]), and the I-year mort
ality rate from 39% to 26% (adjusted hazard ratio [HR] 0.64 [0.54-0.75]), r
espectively. In the 1992-1996 cohort, the adjusted risk of 7-day, 30-day, a
nd I-year mortality for patients with recurrent AMI treated with thrombolys
is in comparison to patients without thrombolysis was OR 1.69 (1.07-2.65),
1.51 (1.03-2.23), and HR 1.18 (0.90-1.55), respectively. The mortality rate
among patients treated with early percutaneous transluminal coronary angio
plasty/coronary artery bypass grafting was 3% versus 12% at 7 days (OR 0.36
[0.16-0.73]), 7% versus 18% at 30 days (OR 0.45 [0.25-0.77]), and 16% vers
us 29% at 1 year (HR 0.64 [0.46-0.96]), in comparison to patients without r
evascularization.
Conclusion: The prognosis of patients with recurrent AMI improved significa
ntly during the reperfusion era. Although thrombolysis may have a limited t
herapeutic effect among patients with recurrent AMI, an interventional appr
oach seems more appropriate when indicated. A randomized trial of thromboly
sis versus early revascularization is needed in patients with recurrent AMI
.